178 related articles for article (PubMed ID: 37269163)
21. Serious liver injury induced by Nimesulide: an international collaborative study.
Bessone F; Hernandez N; Mendizabal M; Ridruejo E; Gualano G; Fassio E; Peralta M; Fainboim H; Anders M; Tanno H; Tanno F; Parana R; Medina-Caliz I; Robles-Diaz M; Alvarez-Alvarez I; Niu H; Stephens C; Colombato L; Arrese M; Reggiardo MV; Ono SK; Carrilho F; Lucena MI; Andrade RJ
Arch Toxicol; 2021 Apr; 95(4):1475-1487. PubMed ID: 33759010
[TBL] [Abstract][Full Text] [Related]
22. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury.
Suzuki A; Brunt EM; Kleiner DE; Miquel R; Smyrk TC; Andrade RJ; Lucena MI; Castiella A; Lindor K; Björnsson E
Hepatology; 2011 Sep; 54(3):931-9. PubMed ID: 21674554
[TBL] [Abstract][Full Text] [Related]
23. Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.
Castiella A; Zapata E; Lucena MI; Andrade RJ
World J Hepatol; 2014 Apr; 6(4):160-8. PubMed ID: 24799984
[TBL] [Abstract][Full Text] [Related]
24. The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative.
Bessone F; Hernandez N; Lucena MI; Andrade RJ;
Int J Mol Sci; 2016 Feb; 17(3):313. PubMed ID: 26938524
[TBL] [Abstract][Full Text] [Related]
25. Autoantibody presentation in drug-induced liver injury and idiopathic autoimmune hepatitis: the influence of human leucocyte antigen alleles.
Stephens C; Castiella A; Gomez-Moreno EM; Otazua P; López-Nevot MÁ; Zapata E; Ortega-Alonso A; Ruiz-Cabello F; Medina-Cáliz I; Robles-Díaz M; Soriano G; Roman E; Hallal H; Moreno-Planas JM; Prieto M; Andrade RJ; Lucena MI
Pharmacogenet Genomics; 2016 Sep; 26(9):414-22. PubMed ID: 27206238
[TBL] [Abstract][Full Text] [Related]
26. Minocycline hepatotoxicity: Clinical characterization and identification of HLA-B∗35:02 as a risk factor.
Urban TJ; Nicoletti P; Chalasani N; Serrano J; Stolz A; Daly AK; Aithal GP; Dillon J; Navarro V; Odin J; Barnhart H; Ostrov D; Long N; Cirulli ET; Watkins PB; Fontana RJ; ; ;
J Hepatol; 2017 Jul; 67(1):137-144. PubMed ID: 28323125
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced liver injury with autoimmune features.
deLemos AS; Foureau DM; Jacobs C; Ahrens W; Russo MW; Bonkovsky HL
Semin Liver Dis; 2014 May; 34(2):194-204. PubMed ID: 24879983
[TBL] [Abstract][Full Text] [Related]
28. Rechallenge in idiosyncratic drug-induced liver injury: An analysis of cases in two large prospective registries according to existing definitions.
Pinazo-Bandera JM; Niu H; Alvarez-Alvarez I; Medina-Cáliz I; Del Campo-Herrera E; Ortega-Alonso A; Robles-Díaz M; Hernández N; Paraná R; Nunes V; Girala M; Bessone F; Lucena MI; Andrade RJ; García Cortés M
Pharmacol Res; 2024 May; 203():107183. PubMed ID: 38631619
[TBL] [Abstract][Full Text] [Related]
29. Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
Dragutinović N; Barać A; Stevanović G; Đorđić I; Paglietti B; Micić J; Aleksić E; Stojnić J; Martinov Nestorov J
J Infect Dev Ctries; 2022 Oct; 16(10):1660-1663. PubMed ID: 36332223
[TBL] [Abstract][Full Text] [Related]
30. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury.
Medina-Caliz I; Robles-Diaz M; Garcia-Muñoz B; Stephens C; Ortega-Alonso A; Garcia-Cortes M; González-Jimenez A; Sanabria-Cabrera JA; Moreno I; Fernandez MC; Romero-Gomez M; Navarro JM; Barriocanal AM; Montane E; Hallal H; Blanco S; Soriano G; Roman EM; Gómez-Dominguez E; Castiella A; Zapata EM; Jimenez-Perez M; Moreno JM; Aldea-Perona A; Hernández-Guerra M; Prieto M; Zoubek ME; Kaplowitz N; Lucena MI; Andrade RJ;
J Hepatol; 2016 Sep; 65(3):532-42. PubMed ID: 27184533
[TBL] [Abstract][Full Text] [Related]
31. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis.
Foureau DM; Walling TL; Maddukuri V; Anderson W; Culbreath K; Kleiner DE; Ahrens WA; Jacobs C; Watkins PB; Fontana RJ; Chalasani N; Talwalkar J; Lee WM; Stolz A; Serrano J; Bonkovsky HL
Clin Exp Immunol; 2015 Apr; 180(1):40-51. PubMed ID: 25418487
[TBL] [Abstract][Full Text] [Related]
33. Prior drug allergies are associated with worse outcome in patients with idiosyncratic drug-induced liver injury: A machine learning approach for risk stratification.
Niu H; Solis-Muñoz P; García-Cortés M; Sanabria-Cabrera J; Robles-Diaz M; Romero-Flores R; Bonilla-Toyos E; Ortega-Alonso A; Pinazo-Bandera JM; Cabello MR; Bessone F; Hernandez N; Lucena MI; Andrade RJ; Medina-Caliz I; Alvarez-Alvarez I
Pharmacol Res; 2024 Jan; 199():107030. PubMed ID: 38072217
[TBL] [Abstract][Full Text] [Related]
34. Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases.
Febres-Aldana CA; Alghamdi S; Krishnamurthy K; Poppiti RJ
J Clin Transl Hepatol; 2019 Mar; 7(1):21-26. PubMed ID: 30944815
[No Abstract] [Full Text] [Related]
35. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury.
Tsutsui A; Harada K; Tsuneyama K; Senoh T; Nagano T; Takaguchi K; Ando M; Nakamura S; Mizobuchi K; Kudo M
Dig Dis; 2017; 35(6):506-514. PubMed ID: 29040982
[TBL] [Abstract][Full Text] [Related]
37. Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohort.
Allgeier J; Weber S; Todorova R; Neumann J; Gerbes A
Eur J Gastroenterol Hepatol; 2022 Apr; 34(4):457-461. PubMed ID: 35230981
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
Devarbhavi H; Sridhar A; Kurien SS; Gowda V; Kothari K; Patil M; Singh R
Dig Dis Sci; 2023 May; 68(5):2099-2106. PubMed ID: 36484972
[TBL] [Abstract][Full Text] [Related]
39. The clinical features of drug-induced liver injury observed through liver biopsy: focus on relevancy to autoimmune hepatitis.
Ju HY; Jang JY; Jeong SW; Woo SA; Kong MG; Jang HY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Jin SY; Kim HS; Kim BS
Clin Mol Hepatol; 2012 Jun; 18(2):213-8. PubMed ID: 22893872
[TBL] [Abstract][Full Text] [Related]
40. Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature.
Radovanovic M; Dushenkovska T; Cvorovic I; Radovanovic N; Ramasamy V; Milosavljevic K; Surla J; Jecmenica M; Radulovic M; Milovanovic T; Dumic I
Am J Case Rep; 2018 Sep; 19():1152-1161. PubMed ID: 30266895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
